Newsroom

BIOTRONIK, a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) labeling approval of its Selectra 3D catheter in conjunction with its Solia S lead for use in left bundle branch area pacing (LBBAP). The two products represent the first and only FDA-approved stylet-driven lead and dedicated delivery catheter system approved for LBBAP. The Solia S lead and Selectra 3D catheter have been used in more than 80,000 patients worldwide. 1 The additional indication supports their use in the evolving technique of pacing the heart’s natural

BIOTRONIK, a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. The move is being made in response to overwhelming recent clinical data demonstrating superior diagnostics and decreased complication risk of DX compared to traditional high-voltage systems. 1-4 “Based on the current evidence, it is clear we must focus on what is proving to be a lower risk technology with added benefits,” said Dr. Alexander Uhl, BIOTRONIK CEO. “Therefore, we have made the decision to offer only DX

For the first time, a panel of spinal cord stimulation (SCS) experts has developed best practices in the nascent field of remote SCS device management. The recommendations were recently published in Neuromodulation. 1 When cardiac remote monitoring emerged in the early 2000s, an expert consensus responded by establishing a framework of principles to optimize the management of cardiovascular implantable electronic devices (CIEDs) in 2008. Similar wireless technology is available for the treatment of chronic pain patients, and the publication provides critical guidance on best practices to